A0A2J8S6W0 (A0A2J8S6W0_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
Histone-lysine N-methyltransferase EZH2 UniProtKBInterProInteractive Modelling
746 aa; Sequence (Fasta) ;
10 identical sequences: Homo sapiens: Q15910; Pan troglodytes: K7C3W4, A0A803KHR1; Mandrillus leucophaeus: A0A2K6A6R9; Theropithecus gelada: A0A8D2EC40; Macaca nemestrina: A0A2K6DRW9; Macaca mulatta: H9Z6A2; Nomascus leucogenys: A0A2I3GCA7; Chlorocebus sabaeus: A0A0D9R3X6; Colobus angolensis palliatus: A0A2K5ILW0
It is possible new templates exist for this target since these models were created.
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Automethylated PRC2 dimer bound to nucleosome |
Heteromer O75530; P02281; P06897; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; | 99.63 | 2×SAH; | |||
| Structure of Human Polycomb Repressive Complex 2 (PRC2) with oncogenic histone H3K27M peptide |
Heteromer O75530; P68431; Q15022; Q15910; Q92833; | 100.0 | 8×ZN; 1×SAH; | |||
| PRC2-AEBP2-JARID2 bound to H2AK119ub1 nucleosome |
Heteromer O75530; P02281; P06897; P0CG48; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100.0 | 1×MG; 1×SAH; 1×ZN; | |||
| PRC2 monomer bound to nucleosome |
Heteromer O75530; P02281; P62799; P84233; Q09028; Q15022; Q15910; Q6AZJ8; Q6ZN18; | 100.0 | 1×SAH; | |||
| PRC2-J119-450 monomer bound to H1-nucleosome |
Heteromer O75530; P02281; P06897; P07305; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100.0 | 1×SAH; | |||
| Structure of the primary oncogenic mutant Y641N Hs/AcPRC2 in complex with a pyridone inhibitor |
Heteromer G1KPH4; O75530; Q15022; Q15910; | 100 | 1×6BN; 7×ZN; | |||
| Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Extended Active State |
Heteromer O75530; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100.0 | ||||
| Structure of Human Polycomb Repressive Complex 2 (PRC2) with inhibitor |
Heteromer O75530; Q15022; Q15910; Q92833; | 100 | 8×ZN; 1×74D; | |||
| Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Compact Active State |
Heteromer O75530; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 100.0 | ||||
| Cryo-EM structure of PRC2 in complex with the long isoform of AEBP2 |
Heteromer O75530; Q09028; Q15022; Q15910; Q6ZN18; | 100.0 | ||||
| Human Polycomb Repressive Complex 2 in complex with GSK126 inhibitor |
Heteromer O75530; Q15022; Q15910; | 100.0 | 8×ZN; 1×A9G; | |||
| G4 RNA-mediated PRC2 dimer |
Heteromer A0A6I9KXB3; O75530; Q09028; Q15022; Q15910; Q6ZN18; | 99.8 | 14×ZN; | |||
| Human PRC2 - RvLEAM (short) (1:6 molar ratio), cross-linked 10 min |
Heteromer O75530; Q09028; Q15022; Q15910; Q6ZN18; Q92833; | 99.79 | 7×ZN; | |||
| Histone H3 recognition by nucleosome-bound PRC2 subunit EZH2. |
Heteromer P02281; P06897; P62799; P84233; Q15022; Q15910; | 100.0 | 7×ZN; 1×SAH; | |||
| Structure of Hs/AcPRC2 in complex with a pyridone inhibitor |
Heteromer G1KPH4; O75530; Q15022; Q15910; | 100 | 1×6BN; 7×ZN; | |||
| Crystal Structure of an EZH2-EED Complex in an Oligomeric State |
Heteromer O75530; Q15910; | 100.0 | ||||
| EED in complex with PRC2 allosteric inhibitor compound 22 (MAK683) |
Heteromer O75530; Q15910; | 100 | 3×CL; 1×EJR; | |||
| EED in complex with PRC2 allosteric inhibitor compound 7 |
Heteromer O75530; Q15910; | 100 | 2×CL; 1×EKF; | |||
| EED in complex with PRC2 allosteric inhibitor compound 6 |
Heteromer O75530; Q15910; | 100 | 2×CL; 1×EKR; | |||
| EED in complex with an allosteric PRC2 inhibitor EED666 |
Heteromer O75530; Q15910; | 100 | 1×GOL; 1×LQB; | |||
| EED in complex with PRC2 allosteric inhibitor EED162 |
Heteromer O75530; Q15910; | 100 | 1×LQF; | |||
| Crystal structure of EED in complex with EZH2 peptide and compound 11# |
Heteromer O75530; Q15910; | 100 | 1×EJU; | |||
| EED in complex with PRC2 allosteric inhibitor EED709 |
Heteromer O75530; Q15910; | 100 | 1×LQD; | |||
| EED in complex with an allosteric PRC2 inhibitor |
Heteromer O75530; Q15910; | 100 | 1×73K; | |||
| EED in complex with PRC2 allosteric inhibitor compound 8 |
Heteromer O75530; Q15910; | 100 | 1×LQG; | |||
| EED in complex with PRC2 allosteric inhibitor compound 11 |
Heteromer O75530; Q15910; | 100 | 1×LQH; | |||
| Crystal structure of EED [G255D] in complex with EZH2 peptide and EED226 compound |
Heteromer O75530; Q15910; | 100 | 1×GOL; 1×73K; | |||
| EED in complex with PRC2 allosteric inhibitor EED210 |
Heteromer O75530; Q15910; | 100 | 1×LQE; | |||
| Crystal structure of EED in complex with H3K27Me3 peptide and 3-(benzo[d][1,3]dioxol-4-ylmethyl)pip… |
Heteromer O75530; Q15910; | 100 | 1×7W7; | |||
| Crystal structure of EED in complex with H3K27Me3 peptide and 6-(benzo[d][1,3]dioxol-4-ylmethyl)-5,… |
Heteromer O75530; Q15910; | 100 | 1×GOL; 2×YT3; 1×7WD; | |||
| Crystal Structure of Ubl123 with an EZH2 peptide |
Heteromer Q15910; Q93009; | 100 | ||||
| Crystal structure of the EZH2 SET domain | monomer | 100.0 | 1×SO4; 6×ZN; | |||
| Human Enhancer of Zeste (Drosophila) Homolog 2(EZH2) | monomer | 100.0 | 6×ZN; 4×UNX; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5hyn.1.A | monomer | 0.64 | 8×ZN; 1×SAH; | 100.00 | ||